CLINICAL ROLE -
MRSA: Challenges and Updates
Selection of optimal antibiotic therapy is crucial in the treatment of MRSA.
Droxidopa: Managing Neurogenic Hypotension
Though clinically significant, NOH has had few treatment options.
Use of Target-Specific Oral Anticoagulants for Venous Thromboembolism
According to FDA-approved labeling, use of dabigatran and edoxaban for acute VTE treatment requires 5 to 10 days of parenteral anticoagulation.
Patients with Advanced Cancer: Update on Pain Management
Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.
Keytruda by Merck
Keytruda, manufactured by Merck, is indicated for treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and a BRAF inhibitor.
Do Hospitals Still Need a Formulary?
For the last few decades, the formulary has been part of a consistent foundation for all hospital pharmacies.
